CAR-T Cells in Acute Myeloid Leukemia: Where Do We Stand?
Despite recent advances, the prognosis of acute myeloid leukemia (AML) remains unsatisfactory due to disease recurrence and the development of resistance to both conventional and novel therapies. Engineered T cells expressing chimeric antigen receptors (CARs) on their cellular surface represent one...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI AG
2024-05-01
|
| Sarja: | Biomedicines |
| Aiheet: | |
| Linkit: | https://www.mdpi.com/2227-9059/12/6/1194 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|